Arteriovenous Malformations Market is segmented By Treatment (Surgical Removal, Endovascular Embolization, Stereotactic Radiosurgery), By Disease (Bra....
Market Size in USD
CAGR6.8%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 6.8% |
Market Concentration | Medium |
Major Players | Medtronic, Johnson & Johnson, Stryker Corporation, Penumbra Inc., MicroVention, Inc. |
The arteriovenous malformations market is estimated to be valued at USD 3.14 Bn in 2024 and is expected to reach USD 4.99 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.8% from 2024 to 2031. Growing adoption of gamma knife radiosurgery and endovascular embolization is expected to drive the demand. Moreover, increasing healthcare expenditure and availability of advanced treatment options in developing nations will further aid the arteriovenous malformations market expansion over the forecast period.